QIAGEN N.V. announced on June 26, 2025, that its Supervisory Board elected Stephen H. Rusckowski as Chairman, following the Annual General Meeting of Shareholders (AGM). Mr. Rusckowski succeeds Lawrence A. Rosen, who stepped down after 12 years of service on the Supervisory Board.
At the AGM, shareholders approved all proposed resolutions, including the initiation of QIAGEN’s first-ever annual cash dividend. The dividend payment will be $0.25 per ordinary share, totaling approximately $54 million, with a record and ex-date of July 2, 2025, and a payment date of July 10, 2025.
Shareholders also approved a new synthetic share repurchase authorization of up to $500 million. These approvals reinforce QIAGEN’s commitment to returning capital to shareholders while preserving financial flexibility for innovation and long-term growth, aligning with its disciplined capital allocation strategy.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.